secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sotera Health Co (SHC)
CIK:        0001822479
Form:       8-K
Filed at:   2025-02-27T23:59:59+00:00
Accession:  0001822479-25-000012
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sotera Health FY2024 revenue up 4.9% to $1.10B; net income down to $44M; provides 2025 outlook
--------------------------------------------------------------------------------

- Q4 net revenues down 6.5% to $290M; net income $12M ($0.04 EPS) vs $39M ($0.14 EPS) in Q4 2023.
- Full-year net revenues $1.10B (+4.9%); net income $44M ($0.16 EPS) vs $51M ($0.18 EPS) in 2023.
- Adjusted EBITDA $549M (+3.9% YoY); Adjusted EPS $0.70 (down $0.02 YoY).
- 2025 guidance: net revenue growth 4.0%-6.0%, Adjusted EBITDA growth 4.5%-6.5% constant currency.
- CEO highlights 19th consecutive year of revenue growth, >80% customer satisfaction, Sterigenics expansion, Nelson Labs growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822479/000182247925000012/0001822479-25-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822479/000182247925000012/shc-20250227.htm
  HTML page:      https://secwatch.observer/filing/0001822479-25-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer